Costunolide enhances doxorubicin-induced apoptosis in prostate cancer cells via activated mitogen-activated protein kinases and generation of reactive oxygen species

The management of castration-resistant prostate cancer (CRPC) is challenging, attributable to a lack of efficacious therapies. Chemotherapy is one of the most important treatments for CRPC. Doxorubicin has been extensively used in many different tumors and is often combined with other drugs to enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiasheng, Chen, Binshen, Zou, Zhihui, Li, Wei, Zhang, Yiming, Xie, Jinlin, Liu, Chunxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746101/
https://www.ncbi.nlm.nih.gov/pubmed/29296199
http://dx.doi.org/10.18632/oncotarget.22592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746101/
https://www.ncbi.nlm.nih.gov/pubmed/29296199
http://dx.doi.org/10.18632/oncotarget.22592

Ejemplares similares